Effects of the Dopamine D2 Allosteric Modulator, PAOPA, on the Expression of GRK2, Arrestin-3, ERK1/2, and on Receptor Internalization

por Basu, Dipannita, Tian, Yuxin, Bhandari, Jayant, Jiang, Jian Ru, Hui, Patricia, Johnson, Rodney L., Mishra, Ram K.
Publicado 2013

The Dopamine Allosteric Agent, PAOPA, Demonstrates Therapeutic Potential in the Phencyclidine NMDA Pre-clinical Rat Model of Schizophrenia

por Daya, Ritesh P., Bhandari, Jayant, Kooner, Sharnpreet K., Ho, Joella, Rowley, Christopher D., Bock, Nicholas A., Farncombe, Troy, Mishra, Ram K.
Publicado 2018